Year |
Citation |
Score |
2006 |
Mohutsky MA, Anderson GD, Miller JW, Elmer GW. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. American Journal of Therapeutics. 13: 24-31. PMID 16428919 DOI: 10.1097/01.Mjt.0000143695.68285.31 |
0.655 |
|
2003 |
Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Drug interaction potential of soy extract and Panax ginseng. Journal of Clinical Pharmacology. 43: 643-8. PMID 12817527 DOI: 10.1177/0091270003253636 |
0.329 |
|
2001 |
Lam AY, Elmer GW, Mohutsky MA. Possible interaction between warfarin and Lycium barbarum L. The Annals of Pharmacotherapy. 35: 1199-201. PMID 11675844 DOI: 10.1345/Aph.1Z442 |
0.636 |
|
2001 |
Elmer GW. Probiotics: "Living drugs" American Journal of Health-System Pharmacy. 58: 1101-1109. PMID 11449853 DOI: 10.1093/Ajhp/58.12.1101 |
0.354 |
|
2000 |
Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii Clinical Infectious Diseases. 31: 1012-1017. PMID 11049785 DOI: 10.1086/318130 |
0.336 |
|
1999 |
Elmer GW, Vega R, Mohutsky MA, McFarland LV. Variable time of onset ofClostridium difficiledisease initiated by antimicrobial treatment in hamsters Microbial Ecology in Health & Disease. 11. DOI: 10.3402/Mehd.V11I3.7900 |
0.647 |
|
1999 |
Elmer GW, Martin SW, Horner KL, McFarland LV, Levy RH. Survival of Saccharomyces boulardii in the rat gastrointestinal tract and effects of dietary fiber Microbial Ecology in Health and Disease. 11: 29-34. DOI: 10.1080/089106099435899 |
0.319 |
|
1997 |
Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial Clinical Infectious Diseases. 24: 324-333. PMID 9114180 DOI: 10.1093/Clinids/24.3.324 |
0.323 |
|
1996 |
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents: A neglected modality for the treatment and prevention of selected intestinal and vaginal infections Journal of the American Medical Association. 275: 870-876. PMID 8596226 DOI: 10.1001/Jama.275.11.870 |
0.318 |
|
1994 |
Mcfarland LV, Surawicz CM, Elmer GW, Moyer KA, Melcher SA, Fekety R, Bowen KE, Cox JL, Noorani Z, Harrington G, Rubin M, Greenwald D, Greenberg RN. A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease Jama: the Journal of the American Medical Association. 271: 1913-1918. PMID 8201735 DOI: 10.1001/Jama.1994.03510480037031 |
0.325 |
|
1993 |
Klein SM, Elmer GW, McFarland LV, Surawicz CM, Levy RH. Recovery and Elimination of the Biotherapeutic Agent, Saccharomyces boulardii, in Healthy Human Volunteers Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 10: 1615-1619. PMID 8290474 DOI: 10.1023/A:1018924820333 |
0.322 |
|
1991 |
Boddy AV, Elmer GW, McFarland LV, Levy RH. Influence of Antibiotics on the Recovery and Kinetics of Saccharomyces boulardii in Rats Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 8: 796-800. PMID 2062812 DOI: 10.1023/A:1015822605815 |
0.385 |
|
1991 |
McFarland LV, Elmer GW, Stamm WE, Mulligan ME. Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients Infection and Immunity. 59: 2456-2462. PMID 2050409 DOI: 10.1128/Iai.59.7.2456-2462.1991 |
0.302 |
|
1990 |
Kimmey MB, Elmer GW, Surawicz CM, McFarland LV. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii Digestive Diseases and Sciences. 35: 897-901. PMID 2364845 DOI: 10.1007/Bf01536805 |
0.306 |
|
1989 |
Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, Van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study Gastroenterology. 96: 981-988. PMID 2494098 DOI: 10.1016/0016-5085(89)91613-2 |
0.335 |
|
1984 |
Elmer GW, Remmel RP. Role of the intestinal microflora in clonazepam metabolism in the rat Xenobiotica. 14: 829-840. PMID 6506755 DOI: 10.3109/00498258409151481 |
0.573 |
|
1983 |
Remmel RP, Elmer GW. Separation of clonazepam and five metabolites by reverse phase HPLC and quantitation from rat liver microsomal incubations Journal of Liquid Chromatography. 6: 585-598. DOI: 10.1080/01483918308076070 |
0.558 |
|
1981 |
Remmel RP, Elmer GW. The effect of broad-spectrum antibiotics on warfarin excretion and metabolism in the rat Research Communications in Chemical Pathology and Pharmacology. 34: 503-514. PMID 7323446 |
0.574 |
|
1981 |
Remmel RP, Pohl LR, Elmer GW. Influence of the intestinal microflora on the elimination of warfarin in the rat Drug Metabolism and Disposition. 9: 410-414. PMID 6117438 |
0.536 |
|
1977 |
Powell ML, Pope B, Elmer GW, Trager WF. Biliary excretion of warfarin metabolites and their metabolism by rat gut flora Life Sciences. 20: 171-177. PMID 13258 DOI: 10.1016/0024-3205(77)90145-X |
0.367 |
|
1970 |
Elmer GW, Nickerson WJ. Nutritional requirements for growth and yeastlike development of Mucor rouxii under carbon dioxide Journal of Bacteriology. 101: 595-602. PMID 5413828 DOI: 10.1128/Jb.101.2.595-602.1970 |
0.534 |
|
1970 |
Elmer GW, Nickerson WJ. Filamentous growth of Mucor rouxii under nitrogen Journal of Bacteriology. 101: 592-594. PMID 5413827 DOI: 10.1128/Jb.101.2.592-594.1970 |
0.522 |
|
Show low-probability matches. |